Medical products and technologies company Convatec Group Plc (CTEC.L,CNVVY) reported strong year-to-date organic revenue growth of 6.7%, excluding InnovaMatrix, with broad-based gains across all categories. When including InnovaMatrix, organic revenue growth stood at 6.2%, while reported growth reached 5.1%.
The company has tightened its financial guidance for fiscal year 2025. It now expects group organic revenue growth—excluding InnovaMatrix—to be in the range of 5.5%-7.0%, compared to the previous estimate of 5.0%-7.0%. InnovaMatrix revenues are anticipated to reach at least $75 million, while revenue growth guidance for each category remains unchanged.
Additionally, the company remains on track to achieve an adjusted operating profit margin of 22.0-22.5%, an improvement from fiscal year 2024's 21.2%, and is set to deliver another year of double-digit adjusted earnings per share growth.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.